Congress Stalls, Xylazine Spreads
Scholars examine the regulatory void allowing veterinary sedative to infiltrate the drug supply.
Regulating Payment of Participant Data in Clinical Trials
Scholars argue for regulatory changes to encourage paying trial participants for their data.
Rescheduling Cannabis Under the Controlled Substances Act
Experts discuss the path to and implications of rescheduling cannabis.
Regulating Cultivated Meat
Scholars discuss challenges and opportunities in lab-grown meat regulation.
Evaluating FDA Preemption of State Drug Regulation
Scholars argue that federal drug agency actions should take precedence over conflicting state regulations.
Lights, Camera, Deception
Scholars argue that regulators and celebrities must work to halt ads for miracle weight loss products.
Bridging the AI Regulatory Gap Through Product Liability
Scholar proposes applying product liability principles to strengthen AI regulation.
Week in Review
President Trump imposes reciprocal tariffs on over 60 countries, FDA launches PreCheck Program to streamline regulatory review, and more…
Nothing to See Here, Move Along
The Supreme Court’s recent unanimous decision on FDA’s tobacco-authorization authority is utterly unremarkable.
Recent E-Cigarette Decision Leaves Unanswered Questions
A unanimous Supreme Court instructed the Fifth Circuit to reconsider the harmless error rule for agency action.
A New Era of Cosmetics Safety Regulation
Scholars consider how the Modernization of Cosmetics Regulation Act strengthens federal oversight.
Making Drugs Affordable Through Personal Importation
Personal importation is the fastest route to “most-favored-nation” drug pricing.